Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Helena D. Aicher"'
Autor:
Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena D. Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden
Publikováno v:
Psychoactives, Vol 3, Iss 2, Pp 215-234 (2024)
Rationale: Psychedelic research re-emerged from a period of suppression into the so-called psychedelic renaissance. In parallel, most media reporting has shifted from the overstatement of the risks of psychedelics to overly positive hype. As the empi
Externí odkaz:
https://doaj.org/article/f8a758fca75844a9b6eca630d8d1c9c6
Autor:
Helena D. Aicher, Michael J. Mueller, Dario A. Dornbierer, Dila Suay, Claudius Elsner, Ilhui Wicki, Daniel Meling, Luzia Caflisch, Alexandra Hempe, Camilla Steinhart, Jovin Mueller, Robin Von Rotz, Birgit Kleim, Milan Scheidegger
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2024)
BackgroundThere is growing scientific evidence for the therapeutic benefits of the Amazonian plant-based psychedelic “ayahuasca” for neuropsychiatric disorders such as depression and anxiety. However, there are certain challenges when incorporati
Externí odkaz:
https://doaj.org/article/fbee90a9fd9245d2bd6bf8e1dc38067e
Autor:
Dario A. Dornbierer, Laurenz Marten, Jovin Mueller, Helena D. Aicher, Michael J. Mueller, Martina Boxler, Michael Kometer, Davor Kosanic, Robin von Rotz, Maxim Puchkov, Thomas Kraemer, Hans-Peter Landolt, Erich Seifritz, Milan Scheidegger
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Recently, the Amazonian plant medicine “ayahuasca”—containing the psychedelic compound N,N-dimethyltryptamine (DMT) and numerous β-carboline alkaloids, such as harmine—has been suggested to exhibit beneficial effects in patients with affecti
Externí odkaz:
https://doaj.org/article/85b21ff587c744f29a95712b38d1ede7